Cerebrovascular and blood-brain barrier impairments in Huntingtons disease: Potential implications for its pathophysiology
PubMed Lau, D.C.W., Erichsen, L., Svane, M.S., Kster, J., Franek, E., le Roux, C.W., Rigas, G., Rondinone, C.M., Rubino, D., & Satylganova, A
GLP-1RAs have been proposed to have anti-inflammatory properties
Addressing insulin resistance or thyroid imbalances may enhance the benefits of GLP-1 therapy, as these factors are associated with improved metabolic outcomes
Over the entire 52 weeks of the study, AEs occurred in 74.4% of participants randomized to dapagliflozin, the most common were headache, nasopharyngitis, and vitamin D deficiency
We also emphasize ongoing education, so our team remains current with the latest best practices and safety protocols for IV therapy